189 related articles for article (PubMed ID: 23540248)
1. Absolute quantification of NAD(P)H:quinone oxidoreductase 1 in human tumor cell lines and tissues by liquid chromatography-mass spectrometry/mass spectrometry using both isotopic and non-isotopic internal standards.
Tang Z; Wu M; Li Y; Zheng X; Liu H; Cheng X; Xu L; Wang G; Hao H
Anal Chim Acta; 2013 Apr; 772():59-67. PubMed ID: 23540248
[TBL] [Abstract][Full Text] [Related]
2. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
Gasdaska PY; Fisher H; Powis G
Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract][Full Text] [Related]
4. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
Bronsema KJ; Bischoff R; van de Merbel NC
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells.
Winski SL; Koutalos Y; Bentley DL; Ross D
Cancer Res; 2002 Mar; 62(5):1420-4. PubMed ID: 11888914
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma.
Gasdaska PY; Powis G; Hyman P; Fisher H
Cancer Res; 1993 Nov; 53(22):5458-61. PubMed ID: 8221686
[TBL] [Abstract][Full Text] [Related]
9. Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies.
Gu H; Wang J; Aubry AF; Jiang H; Zeng J; Easter J; Wang JS; Dockens R; Bifano M; Burrell R; Arnold ME
Anal Chem; 2012 Jun; 84(11):4844-50. PubMed ID: 22540405
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
11. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
Siegel D; Franklin WA; Ross D
Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
[TBL] [Abstract][Full Text] [Related]
13. Capillary HPLC-ICPMS and tyrosine iodination for the absolute quantification of peptides using generic standards.
Pereira Navaza A; Ruiz Encinar J; Ballesteros A; González JM; Sanz-Medel A
Anal Chem; 2009 Jul; 81(13):5390-9. PubMed ID: 19489591
[TBL] [Abstract][Full Text] [Related]
14. A universal strategy for development of a method for absolute quantification of therapeutic monoclonal antibodies in biological matrices using differential dimethyl labeling coupled with ultra performance liquid chromatography-tandem mass spectrometry.
Ji C; Sadagopan N; Zhang Y; Lepsy C
Anal Chem; 2009 Nov; 81(22):9321-8. PubMed ID: 19842637
[TBL] [Abstract][Full Text] [Related]
15. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
[TBL] [Abstract][Full Text] [Related]
16. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
Hu LT; Stamberg J; Pan S
Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples.
Zhang Y; Li N; Brown PW; Ozer JS; Lai Y
Rapid Commun Mass Spectrom; 2011 Jun; 25(12):1715-24. PubMed ID: 21598331
[TBL] [Abstract][Full Text] [Related]
18. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity LC-MS/MS quantification of peptides and proteins in complex biological samples: the impact of enzymatic digestion and internal standard selection on method performance.
Bronsema KJ; Bischoff R; van de Merbel NC
Anal Chem; 2013 Oct; 85(20):9528-35. PubMed ID: 24010948
[TBL] [Abstract][Full Text] [Related]
20. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer.
Zhao Y; Jia W; Sun W; Jin W; Guo L; Wei J; Ying W; Zhang Y; Xie Y; Jiang Y; He F; Qian X
J Proteome Res; 2010 Jun; 9(6):3319-27. PubMed ID: 20420461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
